GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

AgomAb Therapeutics NV American Depositary Shares AGMB · USD

US listing · 🇺🇸 United States

Compare

7.55

-1.18%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

AgomAb Therapeutics NV American Depositary Shares — daily AGMB Delayed
Market value
$371.8m
Last close × shares
Volume
661.4k
Shares, 9 Nov 2026

About AgomAb Therapeutics NV American Depositary Shares

Its shares trade under the ticker AGMB. It has been listed since 6 February 2026.

AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company, develops novel disease-modifying therapies for immunology and inflammatory diseases in the United States. The company's product pipeline includes Ontunisertib (AGMB-129), an oral gastrointestinal-restricted small molecule inhibitor of ALK5 or TGFßR1 for the treatment of Fibrostenosing Crohn's disease, which is in Phase 2a clinical trials; and AGMB-447, an inhaled small molecule inhibitor of ALK5 or TGFßR1 for the treatment of idiopathic pulmonary fibrosis that is in Phase 1 clinical trials. It also develops AGMB-101, a HGF-mimetic monoclonal antibody that acts through agonism or stimulation of the MET receptor and has demonstrated antifibrotic and regenerative activity in preclinical models. The company was incorporated in 2017 and is headquartered in Antwerp, Belgium.

Figures and description from our data supplier, not checked against the company's own report.

More about AgomAb Therapeutics NV American Depositary Shares →

Latest on AgomAb Therapeutics NV American Depositary Shares

Our reporting

Next results

3 Mar 2027

Due on 3 Mar 2027. Analysts expect earnings of -0.95 a share.

Other United States listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is AgomAb Therapeutics NV American Depositary Shares's ticker?

AgomAb Therapeutics NV American Depositary Shares trades as AGMB on its US listing, under ISIN US00860C1027.

What was AgomAb Therapeutics NV American Depositary Shares's last closing price?

7.55 on 9 Nov 2026. The figure is in USD and is never converted.

When does AgomAb Therapeutics NV American Depositary Shares next report results?

Results are expected on 3 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.